Early appearance of neutralizing antibodies during acute hepatitis C virus (HCV) infection is associated with spontaneous viral clearance. However, the longitudinal changes in antigen-specific memory B cell (MBCs) associated with divergent HCV infection outcomes remain undefined. We characterized longitudinal changes in E2 glycoprotein-specific MBCs from subjects who either spontaneously resolved acute HCV infection or progressed to chronic infection, using single-cell RNA-seq and functional assays. HCV-specific antibodies in plasma from chronically infected subjects recognized multiple E2 genotypes, while those from spontaneous resolvers exhibited variable cross-reactivity to heterotypic E2. E2-specific MBCs from spontaneous resolvers peaked early after infection (4–6 months), following expansion of activated circulating T follicular helper cells (cTfh) expressing interleukin 21. In contrast, E2-specific MBCs from chronically infected subjects, enriched in VH1-69, expanded during persistent infection (> 1 year), in the absence of significantly activated cTfh expansion. Early E2-specific MBCs from spontaneous resolvers produced monoclonal antibodies (mAbs) with fewer somatic hypermutations and lower E2 binding but similar neutralization as mAbs from late E2-specific MBCs of chronically infected subjects. These findings indicate that early cTfh activity accelerates expansion of E2-specific MBCs during acute infection, which might contribute to spontaneous clearance of HCV.
Eduardo Salinas, Maude Boisvert, Amit A. Upadhyay, Nathalie Bédard, Sydney A. Nelson, Julie Bruneau, Cynthia A. Derdeyn, Joseph Marcotrigiano, Matthew J. Evans, Steven E. Bosinger, Naglaa H. Shoukry, Arash Grakoui
Title and authors | Publication | Year |
---|---|---|
Characterization of antibody-dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes.
Adhikari A, Abayasingam A, Brasher NA, Kim HN, Lord M, Agapiou D, Maher L, Rodrigo C, Lloyd AR, Bull RA, Tedla N |
Journal of Medical Virology | 2024 |
Coordinated expansion of memory T follicular helper and B cells mediates spontaneous clearance of HCV reinfection
Eisa M, Gomez-Escobar E, Bédard N, Abdeltawab NF, Flores N, Mazouz S, Fieffé-Bédard A, Sakayan P, Gridley J, Abdel-Hakeem MS, Bruneau J, Grakoui A, Shoukry NH |
Frontiers in immunology | 2024 |
Concerted synergy between viral-specific IgG and CD8+ T cells is critical for clearance of an HCV-related rodent hepacivirus
Gridley J, Holland B, Salinas E, Trivedi S, Dravid P, Elrod E, Jin F, Kumari A, Batista MN, Thapa M, Rice CM, Marcotrigiano J, Kapoor A, Grakoui A |
Hepatology | 2024 |
Update on Hepatitis C Vaccine: Results and Challenges
Garbuglia AR, Pauciullo S, Zulian V, Del Porto P |
Viruses | 2024 |
Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies
Gomez-Escobar E, Roingeard P, Beaumont E |
Viruses | 2023 |
Immunological Monitoring in Hepatitis C Virus Controlled Human Infection Model.
Shoukry NH, Cox AL, Walker CM |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023 |
SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies.
Wang Z, Yang X, Mei X, Zhou Y, Tang Z, Li G, Zhong J, Yu M, Huang M, Su X, Lin B, Cao P, Yang J, Ran P |
Signal Transduction and Targeted Therapy | 2022 |
Where do T cell subsets stand in SARS-CoV-2 infection: an update
Tarique M, Suhail M, Naz H, Muhammad N, Tabrez S, Zughaibi TA, Abuzenadah AM, Hashem AM, Shankar H, Saini C, Sharma A |
Frontiers in Cellular and Infection Microbiology | 2022 |
Serum neutralization activity declines but memory B cells persist after cure of chronic hepatitis C
Nishio A, Hasan S, Park H, Park N, Salas JH, Salinas E, Kardava L, Juneau P, Frumento N, Massaccesi G, Moir S, Bailey JR, Grakoui A, Ghany MG, Rehermann B |
Nature Communications | 2022 |
Differential immune transcriptomic profiles between vaccinated and resolved HCV reinfected subjects
Mazouz S, Salinas E, Bédard N, Filali A, Khedr O, Swadling L, Abdel-Hakeem MS, Siddique A, Barnes E, Bruneau J, Grakoui A, Shoukry NH |
PLoS pathogens | 2022 |
Interleukin-21 in Viral Infections
H Asao |
International journal of molecular sciences | 2021 |
A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection
ST Gobran, P Ancuta, NH Shoukry |
Frontiers in immunology | 2021 |
Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial
CC Phelps, CM Walker, JR Honegger |
Viruses | 2021 |
Th1-Biased Hepatitis C Virus-Specific Follicular T Helper-Like Cells Effectively Support B Cells After Antiviral Therapy
K Zoldan, S Ehrlich, S Killmer, K Wild, M Smits, M Russ, AM Globig, M Hofmann, R Thimme, T Boettler |
Frontiers in immunology | 2021 |
Towards a Systems Immunology Approach to Understanding Correlates of Protective Immunity against HCV
NH Shoukry |
Viruses | 2021 |
Antibiotic Combined with Epitope-Specific Monoclonal Antibody Cocktail Protects Mice Against Bacteremia and Acute Pneumonia from Methicillin-Resistant Staphylococcus aureus Infection
LL Duan, J Zhang, Z Chen, Q Gou, Q Xiong, Y Yuan, H Jing, J Zhu, L Ni, Y Zheng, Z Liu, X Zhang, H Zeng, Q Zou, Z Zhao |
Journal of inflammation research | 2021 |
T cell responses during HBV and HCV infections: similar but not quite the same?
Shoukry NH, Walker CM |
Current Opinion in Virology | 2021 |